Want to join the conversation?
$ABT, which competes with $MDT, $JNJ, and $BSX, said for 2Q16 the company expects an adjusted gross margin ratio of somewhat above 57%, adjusted R&D investment somewhat above 6.5% of sales and adjusted SG&A expense of around 31.5% of sales. The company also expects specified items of $0.14 in 2Q16.
$WBA is yet to receive US anti-trust clearance for its Rite Aid acquisition. The deadline for the deal expires on January 27.
$BMY plunge 7.2%. No credits to the non-acceleration of approval for lung cancer combination treatment.
Well this is big! I don’t know if it’s someone’s monopoly or genuine excitement, but either way, $CSX is up 23% after market closed. I heard some activist investor is going to blow big money into CSX Corp. Anyone mind explaining?